Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
Everly MJ, Everly JJ, Susskind B, Brailey P, Arend LJ, Alloway RR, Roy-Chaudhury P, Govil A, Mogilishetty G, Rike AH, Cardi M, Wadih G, Tevar A, Woodle ES.
Everly MJ, et al. Among authors: alloway rr.
Transplantation. 2008 Dec 27;86(12):1754-61. doi: 10.1097/TP.0b013e318190af83.
Transplantation. 2008.
PMID: 19104417